Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein

被引:22
作者
Yao, Zhuocheng [1 ]
Zhang, Lin [2 ]
Duan, Yuange [3 ]
Tang, Xiaolu [3 ]
Lu, Jian [3 ]
机构
[1] Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China
[2] Ocean Univ China, Coll Fishery, Qingdao 266003, Peoples R China
[3] Peking Univ, Ctr Bioinformat, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
COVID-19; SARS-CoV-2; Spike protein; Adaptive mutations; Transmissibility; Immune evasion; RECEPTOR-BINDING DOMAIN; IMMUNE ESCAPE; EFFICIENT REPLICATION; VARIANT; OMICRON; TRANSMISSION; MUTATIONS; VACCINE; HOST; INFECTIVITY;
D O I
10.1016/j.jinf.2024.106121
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has substantially damaged the global economy and human health. The spike (S) protein of coronaviruses plays a pivotal role in viral entry by binding to host cell receptors. Additionally, it acts as the primary target for neutralizing antibodies in those infected and is the central focus for currently utilized or researched vaccines. During the virus's adaptation to the human host, the S protein of SARS-CoV-2 has undergone significant evolution. As the COVID-19 pandemic has unfolded, new mutations have arisen and vanished, giving rise to distinctive amino acid profiles within variant of concern strains of SARS-CoV-2. Notably, many of these changes in the S protein have been positively selected, leading to substantial alterations in viral characteristics, such as heightened transmissibility and immune evasion capabilities. This review aims to provide an overview of our current understanding of the structural implications associated with key amino acid changes in the S protein of SARS-CoV-2. These research findings shed light on the intricate and dynamic nature of viral evolution, underscoring the importance of continuous monitoring and analysis of viral genomes. Through these molecular-level investigations, we can attain deeper insights into the virus's adaptive evolution, offering valuable guidance for designing vaccines and developing antiviral drugs to combat the ever-evolving viral threats. (c) 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:13
相关论文
共 182 条
[1]   Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa [J].
Abdullah, F. ;
Myers, J. ;
Basu, D. ;
Tintinger, G. ;
Ueckermann, V ;
Mathebula, M. ;
Ramlall, R. ;
Spoor, S. ;
de Villiers, T. ;
Van der Walt, Z. ;
Cloete, J. ;
Soma-Pillay, P. ;
Rheeder, P. ;
Paruk, F. ;
Engelbrecht, A. ;
Lalloo, V ;
Myburg, M. ;
Kistan, J. ;
van Hougenhouck-Tulleken, W. ;
Boswell, M. T. ;
Gray, G. ;
Welch, R. ;
Blumberg, L. ;
Jassat, W. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 :38-42
[2]   Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile [J].
Acevedo, Monica L. ;
Gaete-Argel, Aracelly ;
Alonso-Palomares, Luis ;
de Oca, Marco Montes ;
Bustamante, Andres ;
Gaggero, Aldo ;
Paredes, Fabio ;
Cortes, Claudia P. ;
Pantano, Sergio ;
Martinez-Valdebenito, Constanza ;
Angulo, Jenniffer ;
Le Corre, Nicole ;
Ferres, Marcela ;
Navarrete, Marcelo A. ;
Valiente-Echeverria, Fernando ;
Soto-Rifo, Ricardo .
NATURE MICROBIOLOGY, 2022, 7 (04) :524-+
[3]  
Agency U.H.S, 2021, SARS-CoV-2 variants of concern and variants under investigation.
[4]  
Aguilar-Bretones Muriel, 2023, J Clin Invest, V133, DOI 10.1172/JCI162192
[5]  
Aksamentov I, 2021, J OPEN SOURCE SOFTW, V6, P3773, DOI [10.21105/joss.03773, 10.21105/joss.03773, DOI 10.21105/JOSS.03773]
[6]   SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma [J].
Andreano, Emanuele ;
Piccini, Giulia ;
Licastro, Danilo ;
Casalino, Lorenzo ;
Johnson, Nicole, V ;
Paciello, Ida ;
Dal Monego, Simeone ;
Pantano, Elisa ;
Manganaro, Noemi ;
Manenti, Alessandro ;
Manna, Rachele ;
Casa, Elisa ;
Hyseni, Inesa ;
Benincasa, Linda ;
Montomoli, Emanuele ;
Amaro, Rommie E. ;
McLellan, Jason S. ;
Rappuoli, Rino .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (36)
[7]  
[Anonymous], 2020, WHO coronavirus disease (COVID-19) Dashboard
[8]   The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants [J].
Ao, Danyi ;
He, Xuemei ;
Hong, Weiqi ;
Wei, Xiawei .
MEDCOMM, 2023, 4 (02)
[9]   TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry [J].
Baggen, Jim ;
Jacquemyn, Maarten ;
Persoons, Leentje ;
Vanstreels, Els ;
Pye, Valerie E. ;
Wrobel, Antoni G. ;
Calvaresi, Valeria ;
Martin, Stephen R. ;
Roustan, Chloe ;
Cronin, Nora B. ;
Reading, Eamonn ;
Thibaut, Hendrik Jan ;
Vercruysse, Thomas ;
Maes, Piet ;
Smet, Frederik De ;
Yee, Angie ;
Nivitchanyong, Toey ;
Roell, Marina ;
Franco-Hernandez, Natalia ;
Rhinn, Herve ;
Mamchak, Alusha Andre ;
Young-Chapon, Maxime Ah ;
Brown, Eric ;
Cherepanov, Peter ;
Daelemans, Dirk .
CELL, 2023, 186 (16) :3427-+
[10]   Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies [J].
Baum, Alina ;
Fulton, Benjamin O. ;
Wloga, Elzbieta ;
Copin, Richard ;
Pascal, Kristen E. ;
Russo, Vincenzo ;
Giordano, Stephanie ;
Lanza, Kathryn ;
Negron, Nicole ;
Ni, Min ;
Wei, Yi ;
Atwal, Gurinder S. ;
Murphy, Andrew J. ;
Stahl, Neil ;
Yancopoulos, George D. ;
Kyratsous, Christos A. .
SCIENCE, 2020, 369 (6506) :1014-+